Researchers have been excited about the medication , a novel dual treatment showing significant outcomes in clinical trials for size reduction . It acts by impacting both hormones : GLP-1 and GIP, which https://emiliabzyq503025.post-blogs.com/61606513/this-new-prospect-for-size-loss